InflaRx Eulerpool Ziņas

InflaRx Eulerpool News

InflaRx Akciju Ziņas

InflaRx tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās InflaRx ziņas mēs apkopojam šeit.

• 25. septembris ·

  Yahoo
  InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
• 3. septembris ·

  Yahoo
  InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases
• 3. septembris ·

  Thefly.com
  InflaRx presents new preclinical findings for INF904
• 27. augusts ·

  Yahoo
  InflaRx Announces Participation in September Investor Events
• 13. augusts ·

  TipRanks
  InflaRx Buy Rating Backed by Promising Drug Prospects and Financial Stability
• 12. augusts ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Krystal Biotech (KRYS) and InflaRx (IFRX)
• 8. augusts ·

  Yahoo
  InflaRx N.V. (IFRX) Reports Q2 Loss, Lags Revenue Estimates
• 8. augusts ·

  InvestorPlace
  IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q2 2024
• 8. augusts ·

  Yahoo
  InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update
• 8. augusts ·

  TipRanks
  InflaRx Buy Rating Affirmed: Financial Stability and Gohibic’s Market Potential